Pharmaceuticals, Biotechnology and Life Sciences
SAN DIEGO–(BUSINESS WIRE)–$ARCT #BiotechShowcase–Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused…
Veteran leaders bring deep scientific and clinical expertise as Jnana advances its pipeline toward the clinic BOSTON–(BUSINESS WIRE)–Jnana Therapeutics, a…
Successful additions of ERAS-601 and ERAS-007, potential best-in-class inhibitors of SHP2 and ERK, respectively, enable “MAPK Clamp” approach to shut…
BURLINGTON, N.C.–(BUSINESS WIRE)–Labcorp (NYSE: LH), a leading global life sciences company, today announced that Dr. Brian Caveney, chief medical officer…
BOSTON–(BUSINESS WIRE)–Entrada Therapeutics, a privately-held biotechnology company dedicated to transforming the treatment of devastating diseases using intracellular biologics, today announced…
RADNOR, Pa.–(BUSINESS WIRE)–#HCWBioConnect—Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare…
NEW YORK–(BUSINESS WIRE)–SK Capital Partners LP, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, today…
WALTHAM, Mass.–(BUSINESS WIRE)–Axial Therapeutics Inc., a clinical-stage biotechnology company dedicated to building a unique class of gut-restricted therapeutics for central…
Former Biotech Startup and Merck Executive Brings Extensive Development and Commercialization Experience DURHAM, N.C.–(BUSINESS WIRE)–Biomarck Pharmaceuticals, Ltd., a clinical-stage biopharmaceutical…
BOSTON–(BUSINESS WIRE)–AVEO Oncology (Nasdaq: AVEO) today announced that Michael Bailey, president and chief executive officer of AVEO, will participate in…